Literature DB >> 8112600

Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene.

L Cao1, R T Taggart, I M Berquin, K Moin, D Fong, B F Sloane.   

Abstract

Four full-length cDNA clones coding for preprocathepsin B were isolated from a human gastric adenocarcinoma cDNA library (AGS 1-6-30-1) and analyzed for possible sequence modifications that might be linked to altered intracellular trafficking and secretion of cathepsin B (CTSB) in malignant tumors. Comparison of AGS 1-6-30-1 cDNAs with human kidney/hepatoma cDNAs revealed: (1) three potential N-glycosylation sites instead of two, (2) a nucleotide (nt) substitution in the coding region for the propeptide from GTG to CTG which would result in a Val26-->Leu change, (3) three silent nt replacements in the coding region for the mature protein, (4) five single-nt differences in the 5'- and 3'-UTR (untranslated regions), (5) heterogeneity in the 5'-UTR, and (6) a 10-bp insertion in the 3'-UTR. The 10-bp insertion in the 3'-UTR may alter the stability of CTSB mRNA transcripts and thereby the expression of CTSB. These clones should be useful for expressing human tumor CTSB and analyzing the function of this enzyme in malignant progression. Two restriction-fragment length polymorphisms (RFLPs), EcoRI and TaqI, were detected by Southern blot analysis of genomic DNA from 36 unrelated Caucasians. Inheritance and distribution of the EcoRI alleles (13.0 and 11.0 kb) and the TaqI alleles (5.7 and 4.6 kb) indicated they were independent polymorphisms. In contrast to the EcoRI alleles of 13.0 and 11.0 kb observed in the population survey, genomic DNA from two AGS gastric adenocarcinoma subclones revealed two EcoRI alleles of 13.0 and 7.8 kb.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112600     DOI: 10.1016/0378-1119(94)90750-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Expression of functional recombinant human procathepsin B in mammalian cells.

Authors:  W P Ren; R Fridman; J R Zabrecky; L D Morris; N A Day; B F Sloane
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

2.  Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis.

Authors:  S Mahurkar; M M Idris; D N Reddy; S Bhaskar; G V Rao; V Thomas; L Singh; G R Chandak
Journal:  Gut       Date:  2006-02-21       Impact factor: 23.059

3.  Overexpression and localization of cathepsin B during the progression of human gliomas.

Authors:  M Sivaparvathi; R Sawaya; S W Wang; A Rayford; M Yamamoto; L A Liotta; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

4.  Gene expression analysis for pneumonia caused by Gram-positive bacterial infection.

Authors:  Rufu Jia; Jingyan Yang; Ying Cui; Dongjie Guo; Tiejun Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

Review 5.  An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.

Authors:  Pattaya Seeree; Phorutai Pearngam; Supeecha Kumkate; Tavan Janvilisri
Journal:  Int J Genomics       Date:  2015-09-02       Impact factor: 2.326

6.  Daughter Cells and Erythroid Cells Budding from PGCCs and Their Clinicopathological Significances in Colorectal Cancer.

Authors:  Dan Zhang; Xiaoyun Yang; Zhengduo Yang; Fei Fei; Shuyuan Li; Jie Qu; Mingqing Zhang; Yuwei Li; Xipeng Zhang; Shiwu Zhang
Journal:  J Cancer       Date:  2017-02-11       Impact factor: 4.207

7.  De novo assembly of the sea cucumber Apostichopus japonicus hemocytes transcriptome to identify miRNA targets associated with skin ulceration syndrome.

Authors:  Pengjuan Zhang; Chenghua Li; Lin Zhu; Xiurong Su; Ye Li; Chunhua Jin; Taiwu Li
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

8.  Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer.

Authors:  Leila Akkari; Vasilena Gocheva; Marsha L Quick; Jemila C Kester; Alison K Spencer; Alfred L Garfall; Robert L Bowman; Johanna A Joyce
Journal:  Genes Dev       Date:  2016-01-15       Impact factor: 11.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.